VivoPower PLC is engaged in building, owning, and leasing powered land and data center infrastructure for AI compute applications... Show more
a manufacturer of diagnostic products
Industry ComputerCommunications
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| PMSE | 26.62 | -0.06 | -0.24% |
| PGIM S&P 500 Max Buffer ETF - September (PMSE) | |||
| VTES | 99.00 | -0.29 | -0.30% |
| Vanguard Short-Term Tax Exempt Bond ETF (VTES) | |||
| MBOX | 40.63 | -0.37 | -0.91% |
| Freedom Day Dividend ETF (MBOX) | |||
| BASG | 28.13 | -0.30 | -1.04% |
| Brown Advisory Sustainable Growth ETF (BASG) | |||
| RIFR | 27.11 | -0.37 | -1.35% |
| Russell Investments Global Infrastructure ETF (RIFR) | |||
A.I.dvisor indicates that over the last year, VIVO has been loosely correlated with INSP. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if VIVO jumps, then INSP could also see price increases.
| Ticker / NAME | Correlation To VIVO | 1D Price Change % | ||
|---|---|---|---|---|
| VIVO | 100% | +0.26% | ||
| INSP - VIVO | 41% Loosely correlated | -3.14% | ||
| ICLR - VIVO | 38% Loosely correlated | -1.92% | ||
| BRKR - VIVO | 37% Loosely correlated | -2.52% | ||
| OSPN - VIVO | 37% Loosely correlated | +3.33% | ||
| GMED - VIVO | 36% Loosely correlated | -1.64% | ||
More | ||||
| Ticker / NAME | Correlation To VIVO | 1D Price Change % |
|---|---|---|
| VIVO | 100% | +0.26% |
| Computer Communications industry (168 stocks) | 13% Poorly correlated | -0.48% |
| biotechnology industry (202 stocks) | 11% Poorly correlated | -0.47% |
| drugs industry (214 stocks) | 11% Poorly correlated | -0.63% |
| diagnostics industry (19 stocks) | 10% Poorly correlated | +1.92% |
| cancer industry (69 stocks) | 4% Poorly correlated | -0.61% |
VIVO saw its Momentum Indicator move below the 0 level on August 26, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 80 similar instances where the indicator turned negative. In 79 of the 80 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for VIVO turned negative on August 28, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 41 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
VIVO moved below its 50-day moving average on August 18, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VIVO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for VIVO entered a downward trend on September 23, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 56 of 64 cases where VIVO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.
Following a +6.68% 3-day Advance, the price is estimated to grow further. Considering data from situations where VIVO advanced for three days, in 185 of 219 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
The Tickeron PE Growth Rating for this company is 5 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating fairly steady price growth. VIVO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 90 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.559) is normal, around the industry mean (20.388). P/E Ratio (35.336) is within average values for comparable stocks, (157.795). Projected Growth (PEG Ratio) (0.220) is also within normal values, averaging (3.678). Dividend Yield (0.000) settles around the average of (0.004) among similar stocks. P/S Ratio (769.231) is also within normal values, averaging (103.889).
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VIVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.